Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-01-30

Clinical Trial Update: A Follow-up Trial of Proglucamune® in the Treatment of Protective Qi Deficiency, a TCM Condition [NA]

View source ↗

Summary

A completed clinical trial update for Proglucamune® in treating Protective Qi Deficiency, a Traditional Chinese Medicine condition, with results posted in 2024.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Proglucamune (Proglucamune)

Snippet

Sponsor: USANA Health Sciences | Conditions: Protective Qi Insufficiency (a Condition Term From TCM) | NA | Status: COMPLETED | Results posted: 2024-01-30